Rapamycin has the strongest longevity data of any compound tested — but researchers still disagree on how it should be used. Here's what I found.
For decades, Alzheimer's research chased plaque. Now scientists are chasing timing instead. New research on rapamycin — a decades-old, FDA-approved drug — suggests it may help protect high-risk brains for years, but only if it's used before symptoms ever show up. Here's what the science actually says about rapamycin and Alzheimer's prevention.
Could your gut microbiome determine how well rapamycin works for you? Groundbreaking new science says yes — and it opens the door to a more personalized, more powerful approach to longevity medicine.
Rapamycin brain health benefits are rewriting everything science thought it knew about cognitive aging. This comprehensive guide breaks down the seven powerful biological mechanisms through which rapamycin protects the aging brain — backed by peer-reviewed research and explained in clear, accessible detail.
Rapamycin is redefining what medicine thinks is possible — not by treating the diseases of aging, but by targeting the aging process itself at the cellular level.
Rapamycin anti-aging benefits are revolutionizing immune health science. Discover how low-dose rapamycin activates autophagy, reverses immunosenescence, and supercharges vaccine responses — the complete 2026 guide.
Rapamycin bioavailability is not a fixed number — it is an engineering achievement. The same sirolimus molecule can perform dramatically differently depending on its formulation. This article explains the science of NanoCrystal® technology, enteric coatings, and real-world blood-level data to help you make the most informed, effective longevity protocol decisions possible.
Rapamycin — originally developed for transplant patients — is now showing extraordinary promise for cardiovascular health. From reversing arterial stiffness to clearing cellular debris in heart muscle, here is what the science says about its heart-rejuvenating potential.
Discover why rapamycin longevity research — built on a molecule that extended mouse lifespan by up to 60% — is now being tested in humans. Dr. Brad Stanfield's landmark clinical trial explores whether this FDA-approved drug can fight muscle loss, slow biological aging, and redefine how we grow old.
Recent 2025 research has flipped the script on rapamycin and exercise. While many feared this longevity drug would block hypertrophy, new evidence suggests that pulsed dosing actually preserves muscle mass, enhances autophagy, and may even improve training response. Discover the "Sweet Spot" protocol for combining rapamycin with resistance training without sacrificing your strength.
Discover how rapamycin (sirolimus) targets the root biology of skin aging — reducing wrinkles, restoring collagen, and reviving skin at the cellular level. Explore the Drexel University clinical findings, how SiroSkin works, and where to source pharmaceutical-grade sirolimus from RapaShop.
Emerging 2025–2026 clinical research is revealing something remarkable: the crushing exhaustion of Long COVID and ME/CFS isn't weakness — it's a measurable cellular breakdown. A protein called mTOR gets stuck in the "on" position, blocking the body's internal recycling system entirely. Rapamycin is proving to be the most targeted intervention available for restarting it — with 72.5% of ME/CFS patients reporting significant recovery in a landmark Simmaron Research trial.